Cerus (CERS) EBITDA Margin (2010 - 2026)
Cerus' (CERS) quarterly EBITDA Margin came in at 3.23% in Q2 2026, up 329.0% year-over-year from 0.75% in Q2 2025, and down 390.32% quarter-over-quarter from 0.66% in Q1 2026.
Powered by 
Analysis
Cerus (CERS) EBITDA Margin (2010 - 2026) Analysis & Trends
Cerus has disclosed EBITDA Margin across 15 years of filings, most recently posting 3.23% for Q2 2026.
- In Q2 2026, EBITDA Margin rose 329.0% year-over-year to 3.23%; the TTM figure through Jun 2026 stood at 4.61% (up 642.0% YoY), while the FY2021 annual figure was 30.68%, up 2038.0% from the prior year.
- EBITDA Margin came in at 3.23% for Q2 2026 at Cerus, down from 0.66% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 0.66% in Q1 2026 to a low of 26.3% in Q1 2022.
- Average EBITDA Margin over 3 years is 12.25%, with a median of 13.54% recorded in 2025.
- Year-over-year, EBITDA Margin jumped 4405 bps in 2022 and soared 329 bps in 2026.
- Over 3 years, EBITDA Margin stood at 18.82% in 2022, then soared by 65 bps to 6.53% in 2025, then jumped by 50 bps to 3.23% in 2026.
- Per Business Quant data, the three most recent EBITDA Margin figures were 3.23% in Q2 2026, 0.66% in Q1 2026, and 6.53% in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 19.15% |
| 10 | Cerus | 504.42 Mn | 448.16 Mn | 29.53 Mn | -3.23% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.23% |
| Mar 31, 2026 | -0.66% |
| Jun 30, 2025 | -6.53% |
| Mar 31, 2025 | -13.54% |
| Sep 30, 2022 | -18.82% |
| Jun 30, 2022 | -16.67% |
| Mar 31, 2022 | -26.30% |
| Dec 31, 2021 | -10.16% |
| Sep 30, 2021 | -30.79% |
| Jun 30, 2021 | -45.74% |
| Mar 31, 2021 | -70.35% |
| Dec 31, 2020 | -28.38% |
| Sep 30, 2020 | -59.23% |
| Jun 30, 2020 | -67.93% |
| Mar 31, 2020 | -82.76% |
| Dec 31, 2019 | -78.44% |
| Sep 30, 2019 | -94.11% |
| Jun 30, 2019 | -92.22% |
| Mar 31, 2019 | -91.80% |
| Dec 31, 2018 | -93.54% |